Ecuador - the first South American country to receive Bactiguard’s portfolio for Infection Control

Pressmeddelande  •  2013-05-15 16:27 CEST

Phototext: Christian Kinch, CEO, Bactiguard

The Swedish medtech company Bactiguard has signed an exclusivity agreement with Tecnolab Cia Ltda. Guayaquil to represent the complete Bactiguard portfolio for infection control, including urinary, intravenous and respiratory catheters in Ecuador. This is a break through in South America for Bactiguard who already is present in over 25 countries in Europe, Africa and Asia.

“The co-operation with Tecnolab Cia Ltda. Guayaquil is a milestone in Bactiguard’s history - now our unique solution for health care associated infections, HAI, is available on the South American market. We hope we can reduce the number of HAI’s and improve patient safety in Ecuador and eventually all over South America” says Christian Kinch, CEO of Bactiguard.

"In Ecuador, health care associated infections and the use of antibiotics is rising. Therefore I am very much looking forward to this partnership with Bactiguard whose products not only prevent infections, but also reduces the use of antibiotics and saves health care expenditures. We are convinced that the Bactiguard products will be most welcome in Ecuador’s Health Care system” says Lautaro Castillo, Manager and owner of Tecnolab Cia Ltda.Guayaquil, Ecuador.

Health care associated infections (HAI) are the fourth largest cause of death in the world. The Bactiguard® coating has been applied to urinary catheters in the U.S. since 1995 and over 125 million Bactiguard coated catheters have been used in clinical practice all over the world. The Bactiguard technology consists of an extremely thin noble metal coating that reduces bacterial adhesion and is biocompatible.

Press contact:
Linda Nyberg, Vice President International Affairs
Tel: +46 8 440 58 64
linda.nyberg@bactiguard.com
www.bactiguard.com

Bactiguard provides world-leading solutions preventing health care associated infections - the 4th largest cause of death in the western world. By using Bactiguard technology Governments can reduce healthcare cost, lower the use of antibiotics and save lives. The Bactiguard technology consists of an extremely thin noble metal coating that reduces bacterial adhesion and is biocompatible. It can be used on all sorts of medical devices. The Bactiguard® coated urinary catheter has since 1995 been used by more than 125 million patients in the US. Today Bactiguard offers a full range portfolio within infection prevention in the urinary tract, respiratory tract and blood stream.

You haven't completed the steps for your Hosted Newsroom

You haven't entered a correct link to your helper.html file for your Hosted Newsroom. Go to Publish and complete the steps.